These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29293893)

  • 1. Efficacy and Safety of Fosmidomycin-Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon.
    Mombo-Ngoma G; Remppis J; Sievers M; Zoleko Manego R; Endamne L; Kabwende L; Veletzky L; Nguyen TT; Groger M; Lötsch F; Mischlinger J; Flohr L; Kim J; Cattaneo C; Hutchinson D; Duparc S; Moehrle J; Velavan TP; Lell B; Ramharter M; Adegnika AA; Mordmüller B; Kremsner PG
    Clin Infect Dis; 2018 Jun; 66(12):1823-1830. PubMed ID: 29293893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.
    Macintyre F; Adoke Y; Tiono AB; Duong TT; Mombo-Ngoma G; Bouyou-Akotet M; Tinto H; Bassat Q; Issifou S; Adamy M; Demarest H; Duparc S; Leroy D; Laurijssens BE; Biguenet S; Kibuuka A; Tshefu AK; Smith M; Foster C; Leipoldt I; Kremsner PG; Phuc BQ; Ouedraogo A; Ramharter M;
    BMC Med; 2017 Oct; 15(1):181. PubMed ID: 28988541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study.
    Toure OA; Rulisa S; Anvikar AR; Rao BS; Mishra P; Jalali RK; Arora S; Roy A; Saha N; Iyer SS; Sharma P; Valecha N
    Malar J; 2015 Nov; 14():469. PubMed ID: 26608469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
    Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
    Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam.
    Thriemer K; Hong NV; Rosanas-Urgell A; Phuc BQ; Ha do M; Pockele E; Guetens P; Van NV; Duong TT; Amambua-Ngwa A; D'Alessandro U; Erhart A
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7049-55. PubMed ID: 25224002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial.
    Sevene E; Banda CG; Mukaka M; Maculuve S; Macuacua S; Vala A; Piqueras M; Kalilani-Phiri L; Mallewa J; Terlouw DJ; Khoo SH; Lalloo DG; Mwapasa V
    Malar J; 2019 Aug; 18(1):277. PubMed ID: 31429785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
    Toure OA; Valecha N; Tshefu AK; Thompson R; Krudsood S; Gaye O; Rao BHK; Sagara I; Bose TK; Mohanty S; Rao BS; Anvikar AR; Mwapasa V; Noedl H; Arora S; Roy A; Iyer SS; Sharma P; Saha N; Jalali RK; ; Tiacoh L; Enosse S; Tangpukdee N; Kokolomami J; Ndiaye JL; Rao D; Yumva NN; Sidibe B; Mohanty R; Jha AC; Nyirenda M; Starzengruber P; Swoboda P
    Clin Infect Dis; 2016 Apr; 62(8):964-971. PubMed ID: 26908796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria.
    Borrmann S; Issifou S; Esser G; Adegnika AA; Ramharter M; Matsiegui PB; Oyakhirome S; Mawili-Mboumba DP; Missinou MA; Kun JF; Jomaa H; Kremsner PG
    J Infect Dis; 2004 Nov; 190(9):1534-40. PubMed ID: 15478056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013.
    Liu H; Yang HL; Tang LH; Li XL; Huang F; Wang JZ; Li CF; Wang HY; Nie RH; Guo XR; Lin YX; Li M; Wang J; Xu JW
    Malar J; 2015 Feb; 14():47. PubMed ID: 25652213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Dama S; Niangaly H; Djimde M; Sagara I; Guindo CO; Zeguime A; Dara A; Djimde AA; Doumbo OK
    Malar J; 2018 Oct; 17(1):347. PubMed ID: 30290808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria.
    Borrmann S; Adegnika AA; Moussavou F; Oyakhirome S; Esser G; Matsiegui PB; Ramharter M; Lundgren I; Kombila M; Issifou S; Hutchinson D; Wiesner J; Jomaa H; Kremsner PG
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3749-54. PubMed ID: 16127049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China].
    Wang SQ; Christophel E; Lin SG; Meng F; Hu XM; Wang GZ; Liu J; Zeng LH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Feb; 26(1):50-2. PubMed ID: 18637586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria.
    Adoke Y; Zoleko-Manego R; Ouoba S; Tiono AB; Kaguthi G; Bonzela JE; Duong TT; Nahum A; Bouyou-Akotet M; Ogutu B; Ouedraogo A; Macintyre F; Jessel A; Laurijssens B; Cherkaoui-Rbati MH; Cantalloube C; Marrast AC; Bejuit R; White D; Wells TNC; Wartha F; Leroy D; Kibuuka A; Mombo-Ngoma G; Ouattara D; Mugenya I; Phuc BQ; Bohissou F; Mawili-Mboumba DP; Olewe F; Soulama I; Tinto H;
    Malar J; 2021 May; 20(1):222. PubMed ID: 34011358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial.
    Sutanto I; Suprijanto S; Kosasih A; Dahlan MS; Syafruddin D; Kusriastuti R; Hawley WA; Lobo NF; Ter Kuile FO
    Clin Infect Dis; 2013 Mar; 56(5):685-93. PubMed ID: 23175563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
    Bélard S; Ramharter M; Kurth F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children.
    Borrmann S; Adegnika AA; Matsiegui PB; Issifou S; Schindler A; Mawili-Mboumba DP; Baranek T; Wiesner J; Jomaa H; Kremsner PG
    J Infect Dis; 2004 Mar; 189(5):901-8. PubMed ID: 14976608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.